Nantahala Capital Management, LLC Q2 2023 Filing

Filed August 14, 2023

Portfolio Value

$1.0B

Holdings

114

Report Date

Q2 2023

Filing Type

13F-HR

All Holdings (114 positions)

#	Stock	Shares	Value	% Portfolio	Type
101	APSGBPAPTOSE BIOSCIENCES INC	146,232	$679K	0.07%
102	SRTSSENSUS HEALTHCARE INC	185,048	$583K	0.06%
103	TACTTRANSACT TECHNOLOGIES INC	39,500	$354K	0.03%
104	XGNEXAGEN INC	121,894	$353K	0.03%
105	LADRLADDER CAP CORP	27,073	$294K	0.03%
106	DERMJOURNEY MED CORP	178,706	$284K	0.03%
107	LUCDLUCID DIAGNOSTICS INC	199,074	$277K	0.03%
108	EAREARGO INC	54,002	$266K	0.03%
109	—BM TECHNOLOGIES INC	79,212	$236K	0.02%
110	RFLRAFAEL HLDGS INC	72,678	$152K	0.01%
111	CUECUE BIOPHARMA INC	26,760	$98K	0.01%
112	—NOGIN INC	56,425	$74K	0.01%
113	FULCFULCRUM THERAPEUTICS INC	21,370	$71K	0.01%
114	GAIAGAIA INC NEW	23,144	$53K	0.01%

PreviousPage 2 of 2